Abstract:Telomerase is highly expressed in tumor cells, which has become an important target of anticancer drugs. Since many tumor cells were rich in G4-DNA, we investigated the capabilities of these two ruthenium complexes to stabilize G4-DNA. Two ruthenium(II) complexes were synthesized and characterized via electrospray ionization-mass spectrometry. Since many tumor cells were rich in G4-DNA, we investigated the capabilities of these two ruthenium complexes to stabilize G4-DNA. The interactions of these corn. pounds with G-quadruplex DNA have been studied by fluorescence spectroscopy and circular dichroism (CD) spectroscopy. The stabilization of quadruplex DNA to complex 2 was better than complex 1, and complex 2 can induce telomeric G-quadruplex to occur conformation transformation, while complex 1 cannot. The results showed that the interaction of ruthenium complexes with G-quadruplex DNA was related with the plane of ligand. A novel visual method has been developed for making a distinction between ct-DNA and HTG21 by our Ru complexes binding hemin to form the hemin-G-quadruplex DNAzyme. The results showed that in the presence of complex 1 or 2, HTG21 can fold into a G-quadruplex, but CT-DNA cannot form the G-quadruplex structure. The anticancer activities of these complexes were evaluated by using the MTT assay. Interestingly, the anti-tumor activity of complex 2 exhibited greater inhibition to HepG2 cells, suggesting the ruthenium complexes were much less toxic towards normal cells, and speculated that it targeted the telomeric G-quadruplex was play a role on anti-tumor effect. To further evaluate the characteristics of the death induced by complexes 1 and 2-treated cells staining with Hoechst is analyzed by fluorescence microscopy. These results indicated that complex 2 revealed antiproliferative activities by apoptosis. We also used PI staining and flow cytometry to assess whether the ruthenium complex 2 affected cell cycle progression in HepG2 cells. Complex 2 is a potential antitumor drugs that can induce cancer cell death by acting on cell cycle arrest in G1 phase and the formation of DNA fragments (apoptosis characteristics).

A Ruthenium(ii) Complex Capable of Inducing and Stabilizing Bcl-2 G-quadruplex Formation As a Potential Cancer Inhibitor.

Ruthenium (ii) Polypyridyl Complexes Stabilize the Bcl-2 Promoter Quadruplex and Induce Apoptosis of Hela Tumor Cells

Ruthenium(II) Complexes with 2-Phenylimidazo[4,5-f][1,10]phenanthroline Derivatives that Strongly Combat Cisplatin-Resistant Tumor Cells

Polypyridyl Complexes of Ruthenium(Ii): Stabilization of G-Quadruplex Dna and Inhibition of Telomerase Activity

Studies of Ruthenium(ii)-2,2′-bisimidazole Complexes on Binding to G-quadruplex DNA and Inducing Apoptosis in HeLa Cells

Stabilization of G-quadruplex DNA and Inhibition of Telomerase Activity Studies of Ruthenium(ii) Complexes.

Ruthenium(II) polypyridyl complexes as G-quadruplex inducing and stabilizing ligands in telomeric DNA.

Synthesis, DNA-binding and Topoisomerase Inhibitory Activity of Ruthenium(ii) Polypyridyl Complexes

Novel Polypyridyl Ruthenium Complexes Acting As High Affinity DNA Intercalators, Potent Transcription Inhibitors and Antitumor Reagents.

Dinuclear Ruthenium Complexes Display Loop Isomer Selectivity to C-Myc DNA G-quadriplex and Exhibit Anti-Tumour Activity.

Chiral Ruthenium(Ii) Polypyridyl Complexes: Stabilization of G-Quadruplex Dna, Inhibition of Telomerase Activity and Cellular Uptake

Synthesis, DNA-Binding, Anticancer Evaluation, and Molecular Docking Studies of Bishomoleptic and Trisheteroleptic Ru-Diimine Complexes Bearing 2-(2-Pyridyl)-quinoxaline

A Novel Ruthenium(ii)-Polypyridyl Complex Inhibits Cell Proliferation and Induces Cell Apoptosis by Impairing DNA Damage Repair.

Synthesis, characterization and anticancer activity of dinuclear ruthenium(II) complexes linked by an alkyl chain

Synthesis, DNA-binding, molecular docking and cytotoxic activity in vitro evaluation of ruthenium(II) complexes

Ruthenium Complexes Containing 2,6-Bis(benzimidazolyl)pyridine Derivatives Induce Cancer Cell Apoptosis by Triggering Dna Damage-Mediated P53 Phosphorylation

Stabilization of G-quadruplex DNA, Inhibition of Telomerase Activity and Live Cell Imaging Studies of Chiral Ruthenium(ii) Complexes.

Stabilization of Telomere DNA, and Mechanism of Apoptosis of Tumor Cells Induced by Ruthenium Complexes

Synthesis, Characterization and Biological Evaluation of Labile Intercalative Ruthenium(ii) Complexes for Anticancer Drug Screening.

Targeting nucleus DNA with a cyclometalated dipyridophenazineruthenium(II) complex.

A comparative study on in vitro cytotoxicity, cellular uptake, localization and apoptosis-inducing mechanism of two ruthenium(II) complexes